Biomaterials are instrumental in individualized medical technologies targeting regenerative therapies, immunomodulation or diagnostic methods. In addition to direct clinical application, biomaterials play a key role in the development of advanced three-dimensional tissue and disease models as, for example, required in personalized drug screening.
The one-day symposium is organized by three institutes of Leibniz Health Technologies: the Leibniz Institute of New Materials (INM), the Leibniz Institute for Interactive Materials (DWI) and the Leibniz Institute of Polymer Research Dresden (IPF). Those three institutes work in close collaboration within the LGT competence area “Bioactive Interfaces”.
The event will focus on recent developments in adaptive and bioactive materials for individualized approaches of medical technologies. Beyond recent advances in biomaterials science, the symposium will cover the translational perspective, provide an industrial point of view, and give insights on related aspects of health economy and research policy.
KARL STORZ Visitor and Training Centre, Berlin
Scharnhorststraße 3 | 10115 Berlin
22 March 2017, 09:30 – 17:00
Details about the speakers and abstracts in our program.
- Aranzazu del Campo, Leibniz Institute of New Materials, Saarbrücken (INM)
- Martin Möller, Leibniz Institute for Interactive Materials, Aachen (DWI)
- Carsten Werner, Leibniz Institute of Polymer Research Dresden (IPF)
- Karina Weber, Leibniz Health Technologies
- Jens Hellwage, Leibniz Health Technologies
- Sybille Demmler, Leibniz Health Technologies